Skip to search formSkip to main contentSkip to account menu

EP 092

Known as: 5-Heptenoic acid, 7-(3-(1-(((phenylamino)thioxomethyl)hydrazono)ethyl)bicyclo(2.2.1)hept-2-yl)-, (1alpha,2beta(Z),3alpha,4alpha)-(+-)-, EP-092 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The rank orders of potency of prostaglandin D2, prostaglandin F2~, 9~,11fi-prostaglandin F2 and the stable thromboxane A2… 
Highly Cited
1993
Highly Cited
1993
1 The 16‐phenoxy prostaglandin E analogue sulprostone consistently potentiates primary aggregation waves induced by adenosine 5… 
Highly Cited
1991
Highly Cited
1991
1 Thromboxane A2 (TP‐) receptors in human, rat and rabbit platelets and in smooth muscle of guinea‐pig trachea, rat aorta and… 
1990
1990
The rank orders of potency of prostaglandin D2, prostaglandin F2 alpha, 9 alpha,11 beta-prostaglandin F2 and the stable… 
1989
1989
1 The inhibitory effect of a selective prostaglandin H2 (PGH2)/thromboxane A2 receptor antagonist, EP 092, on platelet… 
1989
1989
1 Replacement of the four‐carbon ω‐terminus in 9,11‐endoxy‐10a‐homo prostaglandin H2 with a p‐fluorophenoxy group produces a… 
1987
1987
We examined the effect of glomerular immune complex (IC) deposition on glomerular eicosanoid synthesis and the role of the… 
Highly Cited
1985
Highly Cited
1985
1 The inhibitory effects of three prostanoid analogues, EP 045, EP 092 and pinane thromboxane A2 (PTA2), on the aggregation of…